Zimmer Biomet Holdings, Inc. (ZBH)

101.77 -0.51 (-0.50%) At close: 04:00PM EDT

Zimmer Biomet Holdings, Inc.

345 East Main Street
Warsaw, IN 46580
United States
574 373 3333
https://www.zimmerbiomet.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 18,000

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Ivan Tornos	COO, President, CEO & Director	2.72M	N/A	1975
Mr. Suketu P. Upadhyay	CFO and Executive VP of Finance, Operations & Supply Chain	2.01M	N/A	1969
Mr. Chad F. Phipps	Senior VP, General Counsel & Secretary	1.32M	1.23M	1972
Mr. Sang Yi	President of Asia Pacific	1.38M	N/A	1962
Mr. Wilfred van Zuilen	Group President of Europe, Middle East & Africa	1.47M	N/A	1970
Mr. Paul A. Stellato	VP, Controller & Chief Accounting Officer	N/A	N/A	1975
Dr. Nitin Goyal M.D.	Chief Science, Technology & Innovation Officer	N/A	N/A	N/A
Mr. Shaun Braun	Senior VP and Chief Information & Digital Officer	N/A	N/A	N/A
Ms. Rachel H. Ellingson	Senior VP & Chief Administrative Officer	N/A	N/A	1970
Mr. David M. DeMartino	Senior VP of Investor Relations	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Corporate governance

Zimmer Biomet Holdings, Inc.’s ISS governance QualityScore as of 1 October 2024 is 2. The pillar scores are Audit: 2; Board: 2; Shareholder rights: 3; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.